NCT
INICIO RECIENTES ARCHIVO COVID-19
INICIO RECIENTES ARCHIVO PUBLICAR INSTRUCCIONES
PARA AUTORES COVID-19 ENTRAR / REGISTRARSE HISTORIA NOSOTROS DIRECTORIO CONTACTO
Antecedentes y origen de la epidemia

Ma Eugenia Manjarrez Zavala





2007, Suplemento 1

2007; 66 (S1)






RESUMEN

Durante el siglo pasado se presentaron tres principales pandemias por el virus de influenza que dejaron un devastador número de muertes de seres humanos. La reciente propagación del virus influenza A H5N1 en aves domésticas y silvestres ha incrementado la amenaza de la infección en seres humanos con el subtipo H5N1. El virus se detectó por primera vez en China en 1996, donde causó la muerte de algunos gansos. Se propagó rápidamente a Europa y África, causando la muerte de miles de aves y de más de 100 personas. La zoonosis por este virus altamente patógeno H5N1 ha causado una alarma global por la posibilidad de que evolucione y surja una nueva cepa de virus para humanos. La vigilancia sobre salud, en la mayoría de los países está enfocada en la reducción de la morbilidad y mortalidad, y la OMS ha convocado a todos los países para que tomen medidas para su preparación, para identificar las necesidades prioritarias y para desarrollar un Plan Nacional de Prevención en caso de pandemia por influenza. El éxito de estas acciones dependerá de los avances de cada miembro de la comunidad internacional.

PALABRAS CLAVE

Influenza, H5N1, pandemia, virus respiratorios.

REFERENCIAS

  1. Stephenson I. H5N1 vaccines: how prepared are we for a pandemic. Lancet 2006; 368: 965-6.

  2. Kobasa D, Jones SM, Shinya K, Kash JC, Ebihara H, Hatta Y, Kim JH, Halfmann P, Hatta M, Feldmann F, Alimonti JB, Fernando L, Li Y, Katze MG, Feldmann H, Kawaoka Y. Aberrant innate immune response in lethal infection of machaques with the 1918 influenza virus. Nature 2007; 445(7125): 267-8.

  3. Lamb AR, Krug MR. Orthomyxoviridae: The viruses and their replication. In: Fields NB, Knipe DM, Huley PM, et al. Virology. Philadelphia: Lippincott-Raven Publishers, 1996: 1353-95.

  4. Macken CA, Webby RJ, Bruno WJ. Genotype turnover by reassortment of replication complex genes from avian influenza A virus. J Gen Virol 2006; 87(Pt 10): 2803-15.

  5. Rabadan R, Levine AJ, Robins H. Comparison of avian and human influenza A viruses reveals a mutational bias on the viral genomes. J Virol 2006; 80(23): 11887-91.

  6. Clem A, Galwankar S. Avian influenza: preparing for a pandemic. J Assoc Physicians India 2006; 54: 563-70.

  7. Nicholls H. Pandemic influenza: The inside story. Plos Biology 2006. www.plos biology/org

  8. Chen GW, Chang SC, Mok CK, Lo YL, Kung YN, Huang JH, Shih YH, Wang JY, Chiang C, Chen CJ, Shih SR. Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis 2006; 12(9): 1353-60.

  9. Maines TR, Chen LM, Matsuoka Y, Chen H, Rowe T, Ortin J, Falcon A, Nguten TH, Mai le O, Sedyaningshi ER, Harun S, Tumpey TM, Donis RO, Cox NJ, Subbarao K, Katz JM, Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci USA 2006; 103(32): 12121-6.

  10. Li Z, Jiang Y, Jiao P, Wang A, Zhao F, Tian G, Wang X, Yu K, Bu Z, Chen H. The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. J Virol 2006; 80(22): 11115-23.

  11. Shinya K, Kawaoka Y. [Influenza virus receptors in the human airway]. Uirusu 2006; 56(1): 85-9.

  12. Webster RG, Govorkova EA. H5N1 influenza continuing evolution and spread. N Engl J Med 2006; 355(21): 2179-85.

  13. Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, Shinya K, Sawada T, Kiso M, Usui T, Murata T. Haemagglutinin mutation responsible for the binding fo H5N1 influenza A viruses to human-type receptors. Nature 2006; 444(7117): 378-82.

  14. Feare CJ, Yasue M. Asymptomatic infection with highly pathogenic avian influenza H5N1 in wild birds: how sound is the evidence? Virol J 2006; 3: 96.

  15. Tanimura N, Tsukamoto K, Okamatsu M, Mase M, Imada T, Nakamura K, Kubo M, Yamaguchi S, Irishio W, Hayashi M, Nakai T, Yamauchi A, Nishimura M, Imai K. Pathology of fatal highly pathogenic H5N1 avian influenza virus infection in large-billed crows (Corvus macrorhynchos) during the 2004 outbreak in Japan. Vet Pathol 2006; 43(4): 500-9.

  16. Woo PC, Lau SK, Yuen KY. Infectious diseases emerging from Chinese wet-markets: zoonotic origins of severe respiratory viral infections. Curr Opin Infect Dis 2006; 19(5):401-7. Manjares- Zavala ME

  17. Balkhy H, Al-Hajjar S. Avian influenza: are our feathers ruffled? Ann Saudi Med 2006; 26(3): 175-82.

  18. Alexander DJ. Avian influenza viruses and human health. Dev Biol 2006; 124: 77-84.

  19. Hrnjakovic-Cvjetkovic I, Cvjetkovic D, Jerant-Patic V, Milosevic V, Tadic-Radovanov J, Kovacevic G. [Avian influenza viruses—new causative agents human infections]. Med Pregl 2006; 59(1-2): 29-32.

  20. Shoham D. Review: molecular evolution and the feasibility of an avian influenza virus becoming a pandemic strain—a conceptual shift. Virus Genes 2006; 33(2): 127-32.

  21. Juckett G. Avian influenza: preparing for a pandemic. Am Fam Physician. 2006; 74(5): 783-90.

  22. Oner AF, Bay A, Arslan S, Akdeniz H, Sahin HA, Cesur Y, Epcacan S, Yilmaz N, Deger I, Kizilyildiz B, Karsen H, Ceyhan M. Avian influenza A (H5N1) infection in eastern Turkey in 2006. N Engl J Med 2006; 355(21): 2174-7.

  23. Smith GJ, Fan XH, Wang J, Li KS, Qin K, Zhang JX, Vijaykrishna D, Cheung CL, Huang K, Rayner JM, Peiris JS, Chen H, Webster RG, Guan Y. Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci USA 2006; 103(45): 16936-41.

  24. Le Menach A, Vergu E, Grais RF, Smith DL, Flahault A. Key strategies for reducing spread of avian influenza among commercial poultry holdings: lessons for transmission to humans. Proc Biol Sci 2006; 273(1600): 2467-75.

  25. Normile D. Panel Confirms Report of Early H5N1 Human Case in China. 2006; 313: 899.

  26. Mase M, Tanimura N, Imada T, Okamatsu M, Tsukamoto K, Yamaguchi S. Recent H5N1 avian influenza A virus increases rapidly in virulence to mice after a single passage in mice. J Gen Virol 2006; 87: 3655-9.

  27. Weber CJ. Update on preparing for the next influenza pandemic. Dermatol Nurs 2006; 6.18(4): 362.

  28. Ito T, Nelson J, Couciero S, Kelm S, Baum LG, Krauss S, Castrucci M, Donatelli I, Kida H, Paulson JC, Webster RG, Kawaoka Y. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Gen Virol 1998; 72: 7367-73.

  29. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12(10): 1203-7.

  30. Leschnik M, Weikel J, Möstl K, Revilla FS, Wodak E, Bagó Z, Vanek E, Benetka V, Hess M, Thalhammer JG. Subclinical infection with avian influenza A (H5N1) virus in cats. EID Journal 2007; 13(2): 243-47.

  31. Zwart Od, Veldhuijzen IK, Elam G, Aro AR, Abraham T, Bishop GD, Richardus JH, Brug J. Avian influenza risk perception, Europe and Asia. EID Journal 2007; 13: 17-19.

  32. Muramoto Y, Le TQ, Phuong LS, Nguyen T, Nguyen TH, Sakai-Tagawa Y, Horimoto T, Kida H, Kawaoka Y. Pathogenicity of H5N1 Influenza A viruses isolated in Vietnam between late 2003 and 2005. J Vet Med Sci 2006; 68(7): 735-7.

  33. Kandun IN, Wibisono H, Sedyaningsih ER, Yusharmen, Hadisoedarsuno W, Purba W, Santoso H, Septiawati C, Tresnaningsih E, Heriyanto B, Yuwono D, Harun S, Soeroso S, Giriputra S, Blair PJ, Jeremijenko A, Kosasih H, Putnam SD, Samaan G, Silitonga M, Chan KH, Poon LL, Lim W, Klimov A, Lindstrom S, Guan Y, Donis R, Katz J, Cox N, Peiris M, Uyeki TM. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006; 355(21): 2186-94.

  34. Khare S, Agarwal R, Singh R, Lal S. Overview of avian influenza. J Indian Med Assoc 2006; 104(7): 379-80, 382, 384.

  35. Normile N. Human cases create challenges and Puzzles. Science 2007; 315: 32.

  36. Govorkova EA, Webby RJ, Humberd J, Seiler JP, Webster RG. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets again homologous and heterologous challenge. J Infect Dis 2006; 191: 159-67.

  37. Looney MR. Newly recognized causes of acute lung injury: transfusion of blood products, severe acute respiratory syndrome, and avian influenza. Clin Chest Med 2006; 27(4): 591-600.

  38. Halpin J. Avian flu from an occupational health perspective. Arch Environ Occup Health 2005; 60(2): 62-9.

  39. Schunemann HJ, Hill SR, Kakad M, Bellamy R, Uyeki TM, Hayden FG, Yazdanpanah Y, Beigel J, Chotpitayasunondh T, Del Mar C, Farrar J, Tran TH, Ozbay B, Sugaya N, Fukuda K, Shindo N, Stockman L, Vist GE, Croisier A, Nagjdaliyev A, Roth C, Thomson G, Zucker H, Oxman AD. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis. 2007; 7(1): 21-31.

  40. Savill NJ, St Rose SG, Keeling MJ, Woolhouse ME. Silent spread of H5N1 in vaccinated poultry. Nature 2006; 442(7104): 757.

  41. L’vov DK. [Population interactions in biological system: influenza virus A—wild and domestic animals—human; reasons and consequences of introduction high pathogenic influenza virus A/H5N1 on Russian territory]. Zh Mikrobiol Epidemiol Immunobiol 2006; (3): 96-100. MEMZ

  42. Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI. Characterization of an influenza A H5N1 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Vaccine 2006; 24(47-48): 6859-66.

  43. Rameix-Welti MA, Agou F, Buchy P, Mardy S, Aubin JT, Veron M, van der Werf S, Naffakh N. Natural variation can significantly alter the sensitivity influenza A (H5N1) viruses to oseltamivir. Antimicrob Agents Chemother 2006; 50(11): 3809-15.

  44. Hui DS, Ip M, Tang JW, Wong AL, Chan MT, Hall SD, Chan PK, Sung JJ. Airflows around oxygen masks: A potential source of infection?. Chest 2006; 130: 822-6.

  45. Odagiri T. [Preparedness and international contribution on H5N1 highly pathogenic avian influenza and pandemic-influenza]. Uirusu 2006; 56(1): 77-84.

  46. Wu JT, Riley S, Fraser C, Leung GM. Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Med 2006; 3(9): 361.

  47. Di Lorenzo L, Soleo L. [The role of the occupational physician in the prevention of the spreading of H5N1 virus avian influenza in exposed workers]. Med Lav 2006; 97(1): 63-9.

  48. Coker R, Mounier-Jack S. Pandemic influenza preparedness in the Asia-Pacific region. Lancet 2006; 368(9538): 886-9.

  49. Holmberg SD, Layton DM, Ghneim GS, Wagener DK. State plans for containment of pandemic influenza. Emerg Infect Dis J 2006; 12: 1414-7.

  50. United Kingdom Department for Education and Skills. Planing for a human influenza p. Guindance to schools and children´s services. 2006; www.teachernet .gov.uk/_doc/9942/FullGuidance.pdf MEMZ

  51. World Health Organization. Cumulative number of conformed human cases of avian influenza (H5N1) reported to WHO[cited 2006 Aug 23]. Available from www.who.int/csr/disease/avian_influenza/country/cases_table_2006_08_21/en/idex.ht

  52. Secretaría de Salud. Plan Nacional de Preparación y Respuesta ante una Pandemia de Influenza. Secretaría de Salud - México 2006. www.salud.gob.mx


2007, Suplemento 1

2007; 66 (S1)